Ignite Creation Date:
2024-05-06 @ 5:45 PM
Last Modification Date:
2024-10-26 @ 2:35 PM
Study NCT ID:
NCT05421780
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2023-11-09
First Post:
2022-05-30
Brief Title:
Post-prandial Glycaemic Controlling Effects of BSG in Singapore Adults With Metabolic Syndrome
Sponsor:
National University of Singapore
Organization:
National University of Singapore
Study Overview
Official Title:
Impact of Brewers Spent Grain BSG and Bio-transformed BSG Biscuits on Post-prandial Glycaemic Controlling Effects in Singapore Adults With Metabolic Syndrome
Status:
ACTIVE_NOT_RECRUITING
Status Verified Date:
2023-11
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The purpose of this study is to assess the glycaemic controlling effects of BSG and bio-transformed BSG-containing biscuits in Singapore adults with MetS The investigators hypothesized that consumption of BSG and bio-transformed BSG containing biscuit will improve glycaemic control
Detailed Description:
This is a double-blind randomised crossover experiment During the 3-week 19 subjects will participate in a 3 meal tolerance test MTT During each MTT session all subjects are required to consume 90 g biscuits either control autoclaved BSG or bio-transformed BSG biscuits and monitored over a period of 240 minutes All three types of biscuits will be consumed at a randomised sequence during this 3-week period Post-prandial blood glucose insulin lipid and amino acid responses breath analysis body composition blood pressure appetite assessment and any other glycaemic biomarkers will be assessed
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None